| Targeting immunometabolism in glioblastoma AA Mohan, WH Tomaszewski, AP Haskell-Mendoza, KM Hotchkiss, ... Frontiers in Oncology 11, 696402, 2021 | 24 | 2021 |
| Designing clinical trials for combination immunotherapy: a framework for glioblastoma K Singh, KA Batich, PY Wen, AC Tan, SJ Bagley, M Lim, M Platten, ... Clinical Cancer Research 28 (4), 585-593, 2022 | 18 | 2022 |
| Enhancing T cell chemotaxis and infiltration in glioblastoma K Singh, KM Hotchkiss, KK Patel, DS Wilkinson, AA Mohan, SL Cook, ... Cancers 13 (21), 5367, 2021 | 18 | 2021 |
| Correcting the drug development paradigm for glioblastoma requires serial tissue sampling K Singh, KM Hotchkiss, IF Parney, J De Groot, S Sahebjam, N Sanai, ... Nature medicine 29 (10), 2402-2405, 2023 | 11 | 2023 |
| For whom the T cells troll? Bispecific T-cell engagers in glioblastoma K Singh, KM Hotchkiss, AA Mohan, JL Reedy, JH Sampson, M Khasraw Journal for Immunotherapy of Cancer 9 (11), 2021 | 11 | 2021 |
| Improving access to Early Intervention in Psychosis (EIP): the 2-week wait for cancer comes to psychosis K Singh, F Ghazi, R White, B Sarfo-Adu, P Carter BMJ Open Quality 7 (3), e000190, 2018 | 9 | 2018 |
| Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis K Singh, AK Kanodia, P Ross, A Torgersen, J Maclean, G Leese, ... British Journal of Neurosurgery 36 (2), 286-289, 2022 | 7 | 2022 |
| Does time of surgery influence the rate of false-negative appendectomies? A retrospective observational study of 274 patients K Singh, MSJ Wilson, M Coats Patient safety in surgery 12, 1-6, 2018 | 5 | 2018 |
| P01. 142 Comparing Outcomes in Glioblastoma Multiforme patients undergoing Photodynamic Therapy with a Second-Generation Photosensitiser vs 5-Aminolevulinic Acid-A Single Site … K Singh, O Kouli, A Kanodia, C Goodman, E Eadie, S Ibbotson, ... Neuro-Oncology 20 (suppl_3), iii265-iii265, 2018 | 4 | 2018 |
| Endovascular and surgical obliteration rates of spinal dural arteriovenous fistulae: a single UK Centre experience K Singh, M Zaben, S Manivannan, J Van Beijnum, J Galea, G Zilani British Journal of Neurosurgery 37 (6), 1613-1618, 2023 | 2 | 2023 |
| Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma SE Zaidi, E Moelker, K Singh, A Mohan, MA Salgado, MA Essibayi, ... BioDrugs 37 (4), 489-503, 2023 | 2 | 2023 |
| Improving the surgical consenting process for patients with acute hip fractures: a pilot quality improvement project K Singh, A Assaf, M Bayley, G Gillespie Patient Safety in Surgery 14, 1-6, 2020 | 2 | 2020 |
| An unusual case of a grade I meningioma with perineural spread M Fadelalla, AK Kanodia, J Brunton, K Singh, A Torgersen, E Sammler, ... British Journal of Neurosurgery 37 (4), 637-640, 2023 | 1 | 2023 |
| Effect of different growing media, Azotobacter and GA3 on growth and survivability of transplanted air layers in Guava (Psidium guajava L.) CV Gwalior-27 VS Kushwah, KV Singh, A Kumar, VK Sahu, L Gujar, A Patel International Journal of AgroChemistry 8 (1), 13-22, 2022 | 1 | 2022 |
| IL-7 mediated upregulation of VLA-4 increases accumulation of adoptively transferred T lymphocytes in murine glioma. K Singh, KM Hotchkiss, SL Cook, P Noldner, Y Zhou, EM Moelker, ... bioRxiv, 2024.04. 01.587634, 2024 | | 2024 |
| DEVELOPING PATIENT SPECIFIC TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH INCREASED TUMOR SPECIFICITY AS A THERAPY FOR GLIOBLASTOMA K Hotchkiss, E Blandford, P Noldner, Y Zhou, K Singh, A Patel, P Fecci, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA K Singh, K Hotchkiss, M Foster, C Railton, E Blandford, E Thomas, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| RTID-07. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA K Singh, C Railton, K Hotchkiss, J Herndon, K Peters, H Friedman, ... Neuro-Oncology 25 (Supplement_5), v260-v260, 2023 | | 2023 |
| Systemic autologous lymphocyte transfer can enhance tumor-infiltrating lymphocyte infiltration in glioblastoma and license co-stimulatory immunotherapy K Singh, KM Hotchkiss, E Moelker, GE Archer, JH Sampson, M Khasraw Cancer Research 83 (7_Supplement), 4061-4061, 2023 | | 2023 |
| Developing non-exhausted tumor infiltrating lymphocytes (TILs) as a therapy for glioblastoma KM Hotchkiss, P Noldner, K Singh, A Patel, P Fecci, S Antonia, BH Shaz, ... Cancer Research 83 (7_Supplement), 3193-3193, 2023 | | 2023 |
John H. Sampson, M.D., Ph.D., M.H.Sc...Wilkins Distinguished Professor and Chief of NeurosurgeryVerified email at duke.edu
